STAT3 and glioblastoma: Napabucasin (BBI608), a small molecule that blocks stem cell activity in cancer cells by targeting the STAT3 pathway, is currently in clinical Phase I/II in combination with TMZ in adult patients with recurrent or progressed GBM (NCT02315534, Table 1).